Wortmannin and LY294002 are two compounds that exhibit strong inhibitory action on phosphoinositide 3-kinases (PI3Ks), enzymes that are fundamental to numerous cellular functions such as growth, proliferation, and survival. By blocking PI3K activity, these inhibitors can alter the PI3K/AKT signaling pathway, which is integral to cell cycle progression and apoptosis mechanisms. The effect of these inhibitors is characterized by their capacity to prevent the activation of downstream targets in the PI3K pathway, potentially resulting in the modulation of proteins controlled by this pathway. Similarly, staurosporine, a potent inhibitor that targets a broad range of protein kinases, has the ability to disrupt multiple cellular pathways. This agent is known for its broad-spectrum kinase inhibition, which can lead to alterations in cell cycle control, signal transduction processes, and programmed cell death. Its analog, U0126, along with PD98059, specifically inhibits MEK, an upstream effector in the MAPK/ERK pathway. This pathway's inhibition can result in a cascade of effects ranging from reduced cell division to altered cellular differentiation and secretion. Rapamycin, or Sirolimus, is distinguished by its selective inhibition of the mTOR pathway, a central regulator of cell growth and metabolism. By inhibiting mTOR, rapamycin can exert a profound influence on cellular processes that are mTOR-dependent, including protein synthesis and autophagy.
The inhibition of p38 MAPK by SB203580 and that of JNK by SP600125 represent targeted approaches to modulate specific branches of the MAPK signaling pathways, which are associated with cellular responses to stress and inflammation. These inhibitors can effectively alter the cellular response to environmental stressors and contribute to the control of apoptotic processes. NF449 showcases its effects by selectively targeting the Gs-alpha GTPase, thereby influencing the signaling associated with G-protein-coupled receptors, which are ubiquitous modulators of transmembrane signaling. Compounds like PP2 and Y-27632 exhibit specificity towards Src family tyrosine kinases and Rho-associated protein kinase (ROCK), respectively. Src kinases are involved in controlling cell growth and differentiation, while ROCK plays a significant role in regulating cell shape, motility, and contraction.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which can affect various signaling pathways, including those regulating cell growth and survival. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A known inhibitor of protein kinases, which can modify numerous signaling pathways, including those involved in cell cycle control and apoptosis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway that regulates cell division, differentiation, and secretion. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another inhibitor of PI3K, impacting pathways that control cell growth, proliferation, and survival. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR (mechanistic target of rapamycin), which is central to a cell's growth and metabolism regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Specifically inhibits p38 MAPK, affecting inflammation response and apoptosis pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which blocks the MAPK/ERK pathway, influencing cell cycle progression and proliferation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), impacting pathways associated with stress response and apoptosis. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A potent and selective inhibitor of Gs-alpha GTPase, which can interfere with G-protein-coupled receptor signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Selectively inhibits Src family tyrosine kinases, which are involved in control of cell growth and differentiation. | ||||||